49,613 Shares in GoHealth, Inc. (NASDAQ:GOCO) Acquired by Citadel Advisors LLC

Citadel Advisors LLC bought a new position in shares of GoHealth, Inc. (NASDAQ:GOCO - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 49,613 shares of the company's stock, valued at approximately $664,000. Citadel Advisors LLC owned approximately 0.22% of GoHealth at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. JPMorgan Chase & Co. raised its position in shares of GoHealth by 99.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 8,437 shares of the company's stock valued at $79,000 after purchasing an additional 4,204 shares during the last quarter. Empowered Funds LLC raised its position in shares of GoHealth by 5.3% in the 4th quarter. Empowered Funds LLC now owns 23,218 shares of the company's stock valued at $311,000 after purchasing an additional 1,170 shares during the last quarter. Geode Capital Management LLC raised its position in shares of GoHealth by 1.7% in the 4th quarter. Geode Capital Management LLC now owns 105,514 shares of the company's stock valued at $1,413,000 after purchasing an additional 1,779 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of GoHealth by 28.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,760 shares of the company's stock valued at $37,000 after purchasing an additional 607 shares during the last quarter. Finally, Russell Investments Group Ltd. raised its position in shares of GoHealth by 41,225.5% in the 4th quarter. Russell Investments Group Ltd. now owns 21,076 shares of the company's stock valued at $282,000 after purchasing an additional 21,025 shares during the last quarter. 24.21% of the stock is currently owned by institutional investors.

GoHealth Stock Performance

Shares of GoHealth stock traded up $0.16 during midday trading on Tuesday, hitting $5.95. The company had a trading volume of 51,744 shares, compared to its average volume of 41,902. GoHealth, Inc. has a 12-month low of $5.40 and a 12-month high of $21.00. The company has a fifty day simple moving average of $9.10 and a 200 day simple moving average of $12.44. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.72. The stock has a market cap of $141.24 million, a price-to-earnings ratio of -1.70 and a beta of 1.71.

GoHealth (NASDAQ:GOCO - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported ($0.47) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.21). GoHealth had a negative net margin of 4.32% and a negative return on equity of 17.17%. The company had revenue of $220.97 million during the quarter, compared to analyst estimates of $225.91 million. As a group, analysts predict that GoHealth, Inc. will post -5.5 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $18.00 price objective on shares of GoHealth in a research report on Monday, May 19th.

GoHealth Profile

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.